Welcome to Feed the Bull - A home for investment information and interaction.


PCOM, KTOS, PBIO - CRWESelect.com Stock News! Points International, Kratos Defense & Security Solutions, Pressure BioSciences

Posted, by CRWESelect Stoc... on March 7th, 2012



http://pennyomega.com/img/pcom.jpg Points International, Ltd. (NASDAQ: PCOM)

Points International, Ltd. (PCOM), owner of the loyalty reward management program platform www.Points.com, announced results for the fourth quarter and full year ended December 31, 2011. Total revenue was $32.9 million for the fourth quarter of 2011. Revenue was up 22% over the $27.0 million reported in the fourth quarter of 2010 and up 14% from the $28.8 million reported in third quarter of 2011. For the twelve months ended December 31, 2011, Points generated total revenue of $123.0 million, up 28% over the $95.7 million reported in the twelve months ended December 31, 2010.

PCOM, conducting business as Points.com, is the global leader in reward currency management, providing multiple eCommerce and technology solutions to the world's leading loyalty brands. Points.com also manages www.points.com, the largest consumer rewards management platform that allows over 3 million users to trade, exchange and redeem points, miles and rewards.

Points.com's solutions enable the management and monetization of loyalty currencies, including frequent flyer miles, hotel points, retailer rewards and credit card points, as well as enhancing loyalty program consumer offerings and back-end operations for more than 50 partners worldwide. Points.com's SaaS products allow eCommerce merchants to add loyalty solutions to their online stores and reward customers for purchases.

For more information about PCOM please visit https://www.points.com


ktos Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS)

Kratos Defense & Security Solutions, Inc. (KTOS), a leading National Security Solutions provider, reported fiscal year 2011 revenues and Adjusted EBITDA of $723.1 million and $91.8 million, increases of 77 percent and 131 percent, respectively, over fiscal year 2010. For the fourth quarter of fiscal 2011, Kratos reported revenues of $218.2 million, an 81 percent increase over the fourth quarter of fiscal 2010. For the second half of fiscal 2011, Kratos generated Adjusted Cash Flow from Operations of $27.2 million. For fiscal year 2011, Kratos reported Adjusted EBITDA of $91.8 million, or 12.7 percent of revenue, an increase of 300 basis points over fiscal year 2010. For the fourth quarter of fiscal 2011, Kratos reported Adjusted EBITDA of $27.0 million, or 12.4 percent of revenue, an increase of 170 basis points over the fourth quarter of 2010.

KTOS is a specialized National Security technology business providing mission critical products, services and solutions for United States National Security priorities. Kratos' core capabilities are sophisticated engineering, manufacturing and system integration offerings for National Security platforms and programs. Kratos' areas of expertise include Command, Control, Communications, Computing, Combat Systems, Intelligence, Surveillance and Reconnaissance (C5ISR), satellite communication systems, unmanned systems, cyber warfare, cyber security, information assurance, critical infrastructure security and weapons systems sustainment. Kratos has primarily an engineering and technical oriented work force of approximately 4,000, many of whom hold an active National Security clearance, including Secret, Top Secret and higher. The vast majority of Kratos' work is performed on a military base, in a secure facility or at a critical infrastructure location. Kratos' primary end customers are United States Federal Government agencies, including the Department of Defense, classified agencies, intelligence agencies and Homeland Security related agencies.

For more information about KTOS please visit http://www.kratosdefense.com


http://pennyomega.com/img/pbio.jpg Pressure BioSciences, Inc. (NASDAQ: PBIO)

Pressure BioSciences, Inc. (PBIO) announced that data supporting important advantages of Pressure BioSciences, Inc.'s powerful and enabling Pressure Cycling Technology ("PCT") Platform were presented last week at the 56th Annual Meeting of the Biophysical Society in San Diego, CA and this week at the 8th Annual US Human Proteomic Organization ("HUPO") Conference in San Francisco, CA.

PBIO is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for forensics, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, histology, and counter-bioterror applications.

For more information about PBIO please visit http://www.pressurebiosciences.com

To view recent article visit URL http://crweselect.com/28943/stock-alerts/crwe-spls-plab-mu-crweselectcom-stock-news-crown-equity-holdings-staples-photronics-micron-technology/

CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the


Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup/


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.


Authored by, CRWESelect Stoc...
Log in or register to post Private Message
Advertise with us

Add new comment

By submitting this form, you accept the Mollom privacy policy.